NOUGUES MAXIMO F
Transaction: 07/06/2026
SELL
Change
-9,386
Price
$8.26
Filing
07/08/2026
Type
SELL
Puma Biotechnology, Inc.
PBYI • Biotechnology
$10.76
▲ +0.55 (+5.39%)
Current price
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$537.01M
Growth
—
Cash Flow
4/5
Trend
Mostly stable
Evidence
Stable or improving margins · 13.6%Positive free cash flow · 0.83Consistent free cash flow · 4/5Reasonable earnings multiple · 9.56Manageable debt level · 0.22
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:29 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$10.76
Change5.39%
Shares Out52.60M
Market Cap$537.01M
Enterprise Value$447.93M
52W Range3.05 - 8.75
Beta1.19
P/E20.10
P/S2.32
P/B3.88
P/FCF9.49
EV/Sales1.94
Price$10.76
Change5.39%
Shares Out52.60M
Market Cap$537.01M
Enterprise Value$447.93M
52W Range3.05 - 8.75
Beta1.19
P/E20.10
P/S2.32
P/B3.88
P/FCF9.49
EV/Sales1.94
EV/EBITDA9.63
EV/FCF7.92
Earnings Yield4.98%
FCF Yield10.53%
Dividend Yield0.00%
Gross Margin74.53%
Oper. Margin16.33%
Profit Margin13.62%
Debt/Eq0.22
Current Ratio2.00
Quick Ratio1.93
Volume453.31K
Avg Volume309.04K
EPS Surprise0.09
Investment DNA
How strong this company looks for long-term investors
77
out of 100
Business Quality
Margins, moat, returns
78/100
Financial Strength
Debt, cash, stability
88/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
92/100
Why this score▼
Stable or improving margins · 13.6%Positive free cash flow · 0.83Consistent free cash flow · 4/5Reasonable earnings multiple · 9.56Manageable debt level · 0.22Healthy liquidity · 2
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 20 analyst votes · 2026-10-19
60/100
Neutral
Bullish
8
Hold
8
Bearish
4
Insider Transactions
Recent executive and insider activity
HUNT DOUGLAS M
Transaction: 07/06/2026
SELL
Change
-8,460
Price
$8.26
Filing
07/08/2026
Type
SELL
AUERBACH ALAN H
Transaction: 07/06/2026
SELL
Change
-44,058
Price
$8.26
Filing
07/08/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| NOUGUES MAXIMO F | SELL | -9,386 | $8.26 | 07/06/2026 | 07/08/2026 |
| HUNT DOUGLAS M | SELL | -8,460 | $8.26 | 07/06/2026 | 07/08/2026 |
| AUERBACH ALAN H | SELL | -44,058 | $8.26 | 07/06/2026 | 07/08/2026 |
| Dorval Allison | SELL | -11,610 | $7.20 | 06/12/2026 | 06/15/2026 |
| MOYES JAY M | SELL | -22,000 | $7.22 | 06/12/2026 | 06/15/2026 |
| Senderowicz Adrian | SELL | -27,000 | $7.20 | 06/12/2026 | 06/15/2026 |
| Stuglik Brian M | SELL | -8,100 | $7.20 | 06/12/2026 | 06/15/2026 |
| WILSON TROY EDWARD | SELL | -10,800 | $7.20 | 06/12/2026 | 06/15/2026 |
| Cesano Alessandra | BUY | +27,000 | Not reported | 06/11/2026 | 06/15/2026 |
| Dorval Allison | BUY | +27,000 | Not reported | 06/11/2026 | 06/15/2026 |
| MOYES JAY M | BUY | +27,000 | Not reported | 06/11/2026 | 06/15/2026 |
| MILLER MICHAEL PATRICK | BUY | +27,000 | Not reported | 06/11/2026 | 06/15/2026 |
| Senderowicz Adrian | BUY | +27,000 | Not reported | 06/11/2026 | 06/15/2026 |
| Stuglik Brian M | BUY | +27,000 | Not reported | 06/11/2026 | 06/15/2026 |
| WILSON TROY EDWARD | BUY | +27,000 | Not reported | 06/11/2026 | 06/15/2026 |
| NOUGUES MAXIMO F | BUY | +66,541 | $6.68 | 02/18/2026 | 02/20/2026 |
| NOUGUES MAXIMO F | BUY | +46,739 | Not reported | 02/18/2026 | 02/20/2026 |
| HUNT DOUGLAS M | BUY | +70,321 | $6.68 | 02/18/2026 | 02/20/2026 |
| HUNT DOUGLAS M | BUY | +49,394 | Not reported | 02/18/2026 | 02/20/2026 |
| AUERBACH ALAN H | BUY | +227,474 | $6.68 | 02/18/2026 | 02/20/2026 |